Coronavirus

Moderna’s candidate mRNA vaccine protected most people from symptomatic or severe COVID-19, fueling greater optimism that the pandemic can be ended

Epidemiologist Céline Gounder sees communication as critical

Institute cites interim review based on 20 cases in trial, but provides little more information on Sputnik V vaccine

ScienceInsider looks at tweeted conspiracy claim and other confusing matters on the Pfizer/BioNtech announcement

Scientists worry changes in the viral genome could make future COVID-19 vaccines less effective

A novel project aims to temporarily protect humans from COVID-19 with a nasal spray

Pfizer and BioNTech announced groundbreaking mRNA vaccine is 90% effective but provide little data so far

Crisis could get much worse before new administration takes power

In Kerala state, health minister K. K. Shailaja is fighting to stem a new surge

Novavax vaccine shows “markedly stronger” responses in early human trials

New measures seek to lower the spread of the coronavirus, but some scientists say Europe should eliminate it

Preventing hot spots of COVID-19 transmission has emerged as a key challenge in the fight against the virus

Encouraging national trends hide a complex picture of “100 epidemics,” some rising, some falling

The Food and Drug Administration held no advisory meeting on antiviral, and the European Union signed contract without knowing of failed trial

A trial showed that nitazoxanide, an antiparasitic drug, lowers virus levels in patients. Scientists say it’s irrelevant

For Akiko Iwasaki, the pandemic has brought new research priorities—and new urgency